Literature DB >> 11706970

Depletion of corticotrophin-releasing factor neurons in the pontine micturition area in multiple system atrophy.

E E Benarroch1, A M Schmeichel.   

Abstract

We sought to determine whether the putative pontine micturition center in the human dorsal pons contains corticotrophin-releasing factor (CRF) neurons, and whether these neurons are depleted in patients with multiple system atrophy and bladder dysfunction. Brains were obtained at autopsy from 4 control subjects and 4 patients with clinical diagnosis of multiple system atrophy, confirmed neuropathologically. Serial 50 microm cryostat sections were obtained throughout the rostral half of the pons, and every eighth section was processed for CRF immunocytochemistry (rabbit polyclonal antibody). Consecutive sections were stained for nicotinamide adenine dinucleotide phosphate diaphorase (NADPH-d) to identify neurons of the laterodorsal tegmental nucleus or for both CRF and NADPH. Locus ceruleus neurons were identified by their neuromelanin content. Abundant CRF immunoreactive neurons were identified in the dorsal pontine tegmentum just ventral to the locus ceruleus. CRF neurons were intermingled with, but distinct from, the NADPH-d-reactive neurons of the laterodorsal tegmental nucleus. In all multiple system atrophy cases, there was a severe depletion of these CRF-immunoreactive neurons (26.6 +/- 3 neurons/section in patients; 73.7 +/- 4 neurons/section in controls). Our results suggest that depletion of CRF neurons in the putative pontine micturition center may contribute to the severe bladder dysfunction that characterizes multiple system atrophy.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11706970     DOI: 10.1002/ana.1258

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  10 in total

Review 1.  Integrated control of lower urinary tract--clinical perspective.

Authors:  Clare J Fowler
Journal:  Br J Pharmacol       Date:  2006-02       Impact factor: 8.739

Review 2.  [Neuromuscular dysfunction of the lower urinary tract dysfunction beyond spinal cord injury and multiple sclerosis. A challenge for urologists].

Authors:  A Reitz; C Fisang; S C Müller
Journal:  Urologe A       Date:  2008-09       Impact factor: 0.639

3.  Spinal cord involvement in Lewy body-related α-synucleinopathies.

Authors:  Raffaele Nardone; Yvonne Höller; Francesco Brigo; Viviana Versace; Luca Sebastianelli; Cristina Florea; Kerstin Schwenker; Stefan Golaszewski; Leopold Saltuari; Eugen Trinka
Journal:  J Spinal Cord Med       Date:  2019-01-08       Impact factor: 1.985

4.  Multiple system atrophy: a disorder targeting the brainstem control of survival.

Authors:  Eduardo E Benarroch
Journal:  Clin Auton Res       Date:  2019-10-24       Impact factor: 4.435

Review 5.  The clinical approach to autonomic failure in neurological disorders.

Authors:  Eduardo E Benarroch
Journal:  Nat Rev Neurol       Date:  2014-05-27       Impact factor: 42.937

6.  α-Synuclein pathology accumulates in sacral spinal visceral sensory pathways.

Authors:  Veronique G VanderHorst; Tamara Samardzic; Clifford B Saper; Matthew P Anderson; Sukriti Nag; Julie A Schneider; David A Bennett; Aron S Buchman
Journal:  Ann Neurol       Date:  2015-05-25       Impact factor: 10.422

Review 7.  Synucleinopathies.

Authors:  Elizabeth A Coon; Wolfgang Singer
Journal:  Continuum (Minneap Minn)       Date:  2020-02

Review 8.  Brainstem in multiple system atrophy: clinicopathological correlations.

Authors:  Eduardo E Benarroch
Journal:  Cell Mol Neurobiol       Date:  2003-10       Impact factor: 5.046

9.  Postnatal expression of corticotropin releasing factor (CRF) in rat urinary bladder.

Authors:  Jennifer LaBerge; Susan E Malley; Beatrice Girard; Kimberly Corrow; Margaret A Vizzard
Journal:  Auton Neurosci       Date:  2008-07-01       Impact factor: 3.145

Review 10.  Modelling progressive autonomic failure in MSA: where are we now?

Authors:  Sylvia Stemberger; Gregor K Wenning
Journal:  J Neural Transm (Vienna)       Date:  2011-01-08       Impact factor: 3.575

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.